|
Îá èíñòèòóòå:
èñòîðèÿ,
îáùèå
ïîëîæåíèÿ,
ñòðóêòóðà,
íàó÷íàÿ
äåÿòåëüíîñòü,
ïëàíû ÍÈÐ,
ëå÷åáíî-äèàãíîñòè÷åñêàÿ ðàáîòà,
âåäóùèå
ó÷åíûå
Íîâîñòè:
íîâèíêè íà ñàéòå
Íàøè èçäàíèÿ:
"Óêðàèíñêèé
ïóëüìîíîëîãè÷åñêèé æóðíàë" (ÓÏÆ),
"Óêðàèíñêèé
õèìèîòåðàïåâòè÷åñêèé æóðíàë" (ÓÕÆ),
"Àñòìà è àëëåðãèÿ"
Îðèãèíàëüíûå ñòàòüè:
îðèãèíàëüíûå íàó÷íûå ñòàòüè, ðàíåå íèãäå íå ïóáëèêîâàâøèåñÿ
Íîâîââåäåíèÿ:
ìåòîäè÷åñêèå ðåêîìåíäàöèè,
èíôîðìàöèîííûå ïèñüìà,
âåäîìñòâåííûå
èíñòðóêöèè,
íîâîââåäåíèÿ,
ìîíîãðàôèè
Ïàòåíòû:
ïàòåíòû è
àâòîðñêèå ñâèäåòåëüñòâà èíñòèòóòà
Îò÷åòû î ÍÈÐ:
ðåôåðàòû
çàêîí÷åííûõ íàó÷íî-èññëåäîâàòåëüñêèõ ðàáîò
Ïîäãîòîâêà êàäðîâ:
àñïèðàíòóðà,
êëèíè÷åñêàÿ îðäèíàòóðà,
êóðñû èíôîðìàöèè è
ñòàæèðîâêè,
â ïîìîùü
àñïèðàíòó è ñîèñêàòåëþ
Íàó÷íûå ôîðóìû:
ðåçîëþöèè è
îáðàùåíèÿ ñúåçäîâ, êîíôåðåíöèé, ñîâåùàíèé...
Èíôîðìàöèÿ äëÿ ñïåöèàëèñòîâ:
îáçîðû
ëèòåðàòóðû, ñòàòèñòè÷åñêàÿ èíôîðìàöèÿ, íîâîå â ëå÷åíèè òóáåðêóëåçà è
íåñïåöèôè÷åñêèõ çàáîëåâàíèé ëåãêèõ...
Èíôîðìàöèÿ äëÿ íàñåëåíèÿ:
ïîëåçíàÿ
èíôîðìàöèÿ î çàáîëåâàíèÿõ ëåãêèõ, èõ ïðîôèëàêòèêå è ëå÷åíèè
|
2006. - ¹ 1.
ÑÎÄÅÐÆÀÍÈÅ / CONTENTS
ÏÅÐÅÄÎÂÀ ÑÒÀÒÒß / EDITORIAL
Þ.
². Ôåùåíêî, Î. ß. Äçþáëèê
ÀÍÒÈÁ²ÎÒÈÊÎÒÅÐÀÏ²ß ÕÂÎÐÈÕ ÍÀ ÍÅÃÎÑϲÒÀËÜÍÓ ÏÍÅÂÌÎÍ²Þ Â
ÀÌÁÓËÀÒÎÐÍÈÕ ÓÌÎÂÀÕ
®
Yu. I. Feshchenko, O. Ya. Dzyublik
ANTIBACTERIAL THERAPY OF OUT-PATIENTS
WITH COMMUNITY-ACQUIRED
PNEUMONIA
ÎÐÈòÍÀËÜͲ ÑÒÀÒÒ² / ÎRIGINALS
Ò. Î. Ïåðöåâà, ß. Â. Ïîïîâè÷
ÀÍÀË²Ç Ê˲Ͳ×ÍÎÃÎ ÏÅÐÅÁ²ÃÓ ÍÅÃÎÑϲÒÀËÜÍί
ÏÍÅÂÌÎͲ¯ Ó ÕÂÎÐÈÕ ÍÀ ÑÒÀÖ²ÎÍÀÐÍÎÌÓ
ÅÒÀϲ ÒÀ ÄÎÑÂ²Ä ÇÀÑÒÎÑÓÂÀÍÍß ÇÀÕÈÙÅÍÎÃÎ ÏÅͲֲ˲ÍÓ
 ÐÅÆÈ̲ ÑÒÓÏÅÍÅÂί ÒÅÐÀϲ¯
®
T. O. Pertseva, Ya. V. Popovich
ANALYSIS OF CLINICAL COURSE OF COMMUNITY-ACQUIRED
PNEUMONIA IN HOSPITALIZED PATIENTS AND THE
EXPERIENCE OF ADMINISTRATION OF PROTECTED
PENICILLIN AS A SEQUENTIAL THERAPY
Í. Ì. Øóáà, Ò. Ä. Âîðîíîâà
ÍÈÇÜÊÎÌÎËÅÊÓËßÐͲ ԲDzÎËÎò×ÍÎ ÀÊÒÈÂͲ ÐÅ×ÎÂÈÍÈ ßÊ
ÏÎÊÀÇÍÈÊ ÍÀßÂÍÎÑÒ² ÔÀÊÒÎв ÐÈÇÈÊÓ ÒÀ
ÅÔÅÊÒÈÂÍÎÑÒ² ˲ÊÓÂÀÍÍß Ó ÕÂÎÐÈÕ ÍÀ
ÍÅÃÎÑϲÒÀËÜÍÓ ÏÍÅÂÌÎͲÞ
®
N. M. Shuba, T. D. Voronova
LOW-MOLECULAR PHYSIOLOGICALLY ACTIVE
SUBSTANCES AS AN INDICATOR OF RISK FACTORS AND TREATMENT EFFICIENCY IN PATIENTS WITH
COMMUNITY-ACQUIRED PNEUMONIA
Â. Â. Ìàêñèì³â
ÑÏÎÍÒÀÍÍÀ ÏÐÎÄÓÊÖ²ß ÖÈÒÎʲͲ ÒÀ ËÅÉÊÎÒвªÍÓ Â4
ÌÎÍÎÖÈÒÀÌÈ/ ÌÀÊÐÎÔÀÃÀÌÈ ÏÅÐÈÔÅвÉÍί ÊÐβ Ó ÕÂÎÐÈÕ ÍÀ
ÍÅÃÎÑϲÒÀËÜÍÓ ÏÍÅÂÌÎͲÞ
®
V. V. Maksymiv
SPONTANEOUS PRODUCTION OF CYTOKINES AND
LEUKOTRIENE B4 BY PERIPHERAL BLOOD MONOCYTES/MACROPHAGES IN PATIENTS WITH COMMUNITY-ACQUIRED
PNEUMONIA
Ñ. Ì. Ïîëèâîäà, Î. Â. Êóëèíè÷
ÎÖ²ÍÊÀ ÅÔÅÊÒÈÂÍÎÑÒ² ÒÀ ÏÅÐÅÍÎÑÈÌÎÑÒ² ÔÒÎÐÕ²ÍÎËÎÍÀ
²²² ÏÎÊÎ˲ÍÍß "ÔËÎÊѲÓÌ"  ÏÎвÂÍßÍͲ Ç ÎÐÈòÍÀËÜÍÈÌ ÏÐÅÏÀÐÀÒÎÌ Â Ë²ÊÓÂÀÍͲ
ÇÀÃÎÑÒÐÅÍÍß ÕÎÇË
®
S. M. Polyvoda, O. V. Kulinich
EFFICACY AND TOLERABILITY OF 3RD GENERATION
FLUOROQUINOLONE FLOXIUM IN COMPARISON WITH
ORIGINAL DRUG IN TREATMENT OF COPD EXACERBATION
Â. Â. Åôèìîâ, Ë. Ñ. Âîåéêîâà, Â. È. Áëàæêî, Ë. Ì. Ñàìîõèíà, È. Â. Òàëàëàé
ÏÐÈÌÅÍÅÍÈÅ ÝÏÀÄÎËÀ Ó ÁÎËÜÍÛÕ ÕÐÎÍÈ×ÅÑÊÈÌ ÎÁÑÒÐÓÊÒÈÂÍÛÌ ÇÀÁÎËÅÂÀÍÈÅÌ ËÅÃÊÈÕ
®
V. V. Yefimov, L. S. Voyeykova, V. I. Blazhko, L. M. Samokhina, I. V. Talalay
APPLICATION OF EPADOL IN PATIENTS WITH CHRONIC
OBSTRUCTIVE PULMONARY
DISEASE
². Ï. Êàéäàøåâ, Ä. Ì. Áîéêî, Â. Â. Ãîðáàòåíêî
ÂÈÊÎÐÈÑÒÀÍÍß ÀÍÒÈÃÎÌÎÒÎÊÑÈ×ÍÈÕ ÏÐÅÏÀÐÀҲ Ó
ÊÎÌÏËÅÊÑÍ²É ÒÅÐÀϲ¯ ÕÂÎÐÈÕ ÍÀ ÕÐÎͲ×ÍÅ ÎÁÑÒÐÓÊÒÈÂÍÅ ÇÀÕÂÎÐÞÂÀÍÍß ËÅÃÅÍÜ ²-²²
ÑÒÀIJ¯
®
I. P. Kaidashev, D. M. Boyko, V. V. Gorbatenko
THE MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY
DISEASE OF ²-²² STAGE USING ANTIHOMOTOXIC PREPARATIONS
Þ. Ì. Êàë³í³÷åíêî, Ì. Ì. Îñòðîâñüêèé
ÎÖ²ÍÊÀ ²ÍÒÅÐËÅÉʲÍÎÂÎÃÎ ÏÐÎÔ²ËÞ ÏÐÈ ÕÐÎͲ×ÍÎÌÓ
ÎÁÑÒÐÓÊÒÈÂÍÎÌÓ ÇÀÕÂÎÐÞÂÀÍͲ ËÅÃÅÍÜ
®
Yu. N. Kalinichenko, M. M. Ostrovskiy
ESTIMATION OF INTERLEUKIN PROFILE IN CHRONIC
OBSTRUCTIVE PULMONARY DISEASE
Â. Ê. Ãàâðèñþê, Í. È. Ãóìåíþê, Í. Ä. Ìîðñêàÿ,
Ò. Â. ßõíèöà, Å. À. Ìåðåíêîâà
ÑÐÀÂÍÈÒÅËÜÍÎÅ ÈÇÓ×ÅÍÈÅ ÂËÈßÍÈß ÐÅÎÑÎÐÁÈËÀÊÒÀ È
ÐÅÎÏÎËÈÃËÞÊÈÍÀ ÍÀ
ÑÎÑÒÎßÍÈÅ ÃÅÌÎÊÎÍÖÅÍÒÐÀÖÈÈ, ÂßÇÊÎÑÒÈ ÊÐÎÂÈ È
ÀÃÐÅÃÀÖÈÎÍÍÎÉ ÑÏÎÑÎÁÍÎÑÒÈ
ÒÐÎÌÁÎÖÈÒÎÂ Ó ÁÎËÜÍÛÕ Ñ ÕÐÎÍÈ×ÅÑÊÈÌ ËÅÃÎ×ÍÛÌ
ÑÅÐÄÖÅÌ È ÕÐÎÍÈ×ÅÑÊÎÉ
ÑÅÐÄÅ×ÍÎÉ ÍÅÄÎÑÒÀÒÎ×ÍÎÑÒÜÞ
®
V. K. Gavrysyuk, N. I. Gumenyuk, N. D. Morskaya,
T. V. Yahnitsa, E. A. Merenkova
COMPARATIVE STUDY OF RHEOSORBILACT AND
RHEOPOLYGLUKIN INFLUENCE ON BLOOD CONCENTRATION, VISCOSITY AND PLATELETS
AGGREGATION IN PATIENTS WITH COR PULONALE AND
CHRONIC HEART FAILURE
Å. À. Ìåðåíêîâà, Í. Å. Ìîíîãàðîâà
ÑÎÑÒÎßÍÈÅ ÀÃÐÅÃÀÖÈÎÍÍÎÉ ÑÏÎÑÎÁÍÎÑÒÈ ÒÐÎÌÁÎÖÈÒΠÏÐÈ ÏÀÒÎËÎÃÈÈ ËÅÃÊÈÕ Ó
ÁÎËÜÍÛÕ ÐÀÇËÈ×ÍÛÕ ÍÎÇÎËÎÃÈ×ÅÑÊÈÕ ÃÐÓÏÏ
®
Ye. A. Merenkova, N. Ye. Monogarova
PLATELETS AGGREGATION IN PATIENTS WITH
VARIOUS PULMONARY DISEASES
Ã. Ï. Ïîáåäüîííà
ÌÅÄÈÊÎ-ÅÊÎÍÎ̲×Ͳ ÀÑÏÅÊÒÈ Ë²ÊÓÂÀÍÍß
ÁÐÎÍÕ²ÀËÜÍί ÀÑÒÌÈ
®
G. P. Pobedyonnaja
MEDICAL AND ECONOMICAL ASPECTS OF EFFECTIVENESS OF ASTHMA THERAPY
²ÍÔÎÐÌÀÖ²ß / INFORMATION
Â. Ï. Êîñòðîìèíà, Ë. Á. ßðîùóê
ÔÐÎÌÈËÈÄ ÓÍÎ - ÍÎÂÀß ÔÎÐÌÀ È ÍÎÂÛÅ ÂÎÇÌÎÆÍÎÑÒÈ Â
ËÅ×ÅÍÈÈ ÇÀÁÎËÅÂÀÍÈÉ ÎÐÃÀÍΠÄÛÕÀÍÈß Ó ÄÅÒÅÉ
®
V. P. Kostromina, L. B. Yaroshchuk
FROMILID-UNO - NOVEL FORMULATION AND
NEW OPPORTUNITIES IN TREATMENT OF RESPIRATORY DISEASES IN CHILDREN
ÀÊÒÓÀËÜͲ ÏÈÒÀÍÍß ÔÒÈDzÀÒв¯ /TOPICAL ISSUES OF PHTHISIATRY
Â. Ì. Ìåëüíèê, ². Î. Íîâîæèëîâà, À. Ì. Ïðèõîäüêî,
Î. Ð. Ñìåòàí³íà
ÄÈÍÀ̲ÊÀ ÇÀÕÂÎÐÞÂÀÍÎÑÒ² ÒÀ ÑÌÅÐÒÍÎÑÒ² ²Ä
ÒÓÁÅÐÊÓËÜÎÇÓ ÄÎ ² Ï²Ä ×ÀÑ ÅϲÄÅ̲¯:
ÒÅÍÄÅÍÖ²¯ ÒÀ ÐÅòÎÍÀËÜͲ ÎÑÎÁËÈÂÎÑÒ²
®
V. M. Melnyk, I. A. Novozhilova, A. N. Prychodko,
O. R. Smetanina
DYNAMICS OF TUBERCULOSIS MORBIDITY AND MORTALITY
BEFORE AND DURING THE EPIDEMIC, REGIONAL
PECULIARITIES
É. Á. Áÿëèê, Ë. Ì. Öèãàíêîâà, Â. Â. Äàâèäåíêî,
². Â. Ñëó÷
ÐÅÇÓËÜÒÀÒÈ ÇÀÑÒÎÑÓÂÀÍÍß ÏÀÑÊ Â ÊÎÌÏËÅÊÑͲÉ
ղ̲ÎÒÅÐÀϲ¯ ÕÂÎÐÈÕ ÄÅÑÒÐÓÊÒÈÂÍÈÌ, ÐÀÍ²Ø ÍÅÅÔÅÊÒÈÂÍΠ˲ÊÎÂÀÍÈÌ,
ղ̲ÎÐÅÇÈÑÒÅÍÒÍÈÌ ÒÓÁÅÐÊÓËÜÎÇÎÌ ËÅÃÅÍÜ
®
I. B. Byalik, L. M. Tsygankova, V. V. Davidenko,
I. V. Slouch
RESULTS OF PASA APPLICATION IN COMPLEX
CHEMOTHERAPY OF PATIENTS WITH DESTRUCTIVE, INEFFECTIVELY TREATED
PREVIOUSLY, RESISTANT PULMONARY TUBERCULOSIS
Î. Ê. Àñìîëîâ, Î. Â. Ïàâëîâà, Ò. Ä. Êîòëÿðîâà
ÀÍÀË²Ç Ë²ÊÀÐÍßÍί ËÅÒÀËÜÍÎÑÒ² ÕÂÎÐÈÕ ÍÀ ÑÏÎËÓ×ÅÍÓ
ÏÀÒÎËÎÃ²Þ Â²Ë/ÑÍ²Ä ÒÀ ÒÓÁÅÐÊÓËÜÎÇ Ó ÒÓÁÑÒÀÖ²ÎÍÀв
®
O. K. Asmolov, O. V. Pavlova, T. D. Kotlyarova
THE ANALYSIS OF MORTALITY AMONG PATIENTS WITH
HIV/AIDS AND TUBERCULOSIS AT TUBERCULOSIS HOSPITAL
È. À. Ñèðåíêî, Ñ. À. Øìàòüêî
ÎÑÎÁÅÍÍÎÑÒÈ L-ÀÐÃÈÍÈÍÇÀÂÈÑÈÌÎÃÎ
ÑÈÍÒÅÇÀ ÎÊÑÈÄÀ ÀÇÎÒÀ Ó ÄÅÒÅÉ È ÏÎÄÐÎÑÒÊÎÂ,
ÁÎËÜÍÛÕ ÒÓÁÅÐÊÓ˨ÇÎÌ ÎÐÃÀÍΠÄÛÕÀÍÈß
®
I. A. Sirenko, S. A. Schmatko
PECULIARITIES OF L-ARGININE-DEPENDENT
SYNTHESIS OF NITRIC OXIDE IN CHILDREN AND ADOLESCENTS WITH TUBERCULOSIS OF RESPIRATORY
ORGANS
ÎÃËßÄÈ Ë²ÒÅÐÀÒÓÐÈ / LITERATURE REVIEW
Ë. Ì. Êóðèê
Ô²ÇÈÊÎ-ղ̲×Ͳ ÀÑÏÅÊÒÈ ÑÈÍÃËÅÒÍÎ-ÊÈÑÍÅÂί
ÒÅÐÀϲ¯ Ó Ë²ÊÓÂÀÍͲ ÏÀÒÎËÎò×ÍÈÕ ÏÐÎÖÅѲÂ
®
L. M. Kurik
PHYSICAL-CHEMICAL ASPECTS
OF SINGLET-OXYGEN THERAPY
OF PATHOLOGICAL CONDITIONS
Ê˲Ͳ×Ͳ ÑÏÎÑÒÅÐÅÆÅÍÍß / CLINICAL OBSERVATIONS
Â. Â. Áóãåðóê, Þ. Â. ̳òàñîâ, Î. Ô. Êîñò³øèí,
Ò. Ä. Íîñîâà
ËÅÃÅÍÅÂÈÉ ÀËÜÂÅÎËßÐÍÈÉ ÏÐÎÒůÍÎÇ-вÄʲÑÍÈÉ Ê˲Ͳ×ÍÈÉ ÂÈÏÀÄÎÊ
®
V. V. Bugeruk, Yu. V. Mitasov, A. F. Kostishin,
T. D. Nosova
PULMONARY ALVEOLAR PROTEINOSIS-RARE CLINICAL CASE
²ÍÔÎÐÌÀÖ²ß / INFORMATION
ÀÂÒÎÐÀÌ ÆÓÐÍÀËÜÍÈÕ ÏÓÁ˲ÊÀÖ²É
®
INSTRUCTIONS TO THE AUTHORS
|